Pharmacokinetics of intravenous ketorolac in cats undergoing gonadectomy

N Z Vet J. 2015 May;63(3):162-6. doi: 10.1080/00480169.2014.987329. Epub 2015 Mar 31.

Abstract

Aim: To determine the pharmacokinetics of ketorolac tromethamine (0.5 mg/kg) when administered I/V to cats undergoing gonadectomy.

Methods: Ketorolac was administered to nine female and three male shorthair domestic cats as an I/V bolus of 0.5 mg/kg after intubation, and 20 minutes prior to ovariectomy or orchiectomy. Intra-operative cardiorespiratory variables were monitored and blood samples were collected over 24 hours. Concentrations of ketorolac in serum were determined by high-performance liquid chromatography to establish pharmacokinetic parameters.

Results: During surgery, mean end tidal isoflurane concentration was 1.63 (SD 0.24)% and normocapnia and spontaneous ventilation were maintained in all animals. The kinetics of ketorolac was described by a two-compartment model. The distribution and elimination half-lives were 0.09 (SD 0.06) and 4.14 (SD 1.18) hours, respectively. The body clearance was 56.8 (SD 33.1) mL/h/kg. The volume of distribution at steady-state and the mean residence time were 323.9 (SD 115.7) mL/kg and 6.47 (SD 2.86) hours, respectively.

Conclusion and clinical relevance: On the basis of the results, concentrations of ketorolac in serum in cats were above the human effective concentrations for 5-6 hours postoperatively. However, other studies including a control group are advocated to further investigate the ketorolac kinetics and the analgesic efficacy in this species.

Keywords: Ketorolac; NSAID; cat; gonadectomy; pharmacokinetics.

Publication types

  • Clinical Trial

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / blood
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
  • Area Under Curve
  • Cats / blood*
  • Female
  • Half-Life
  • Hysterectomy / veterinary*
  • Ketorolac / blood
  • Ketorolac / pharmacokinetics*
  • Male
  • Orchiectomy / veterinary*
  • Ovariectomy / veterinary*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Ketorolac